Introducing GPT-Rosalind for life sciences research
OpenAI
OpenAI has launched GPT-Rosalind, a specialized reasoning model designed to accelerate scientific workflows in biology, drug discovery, and genomics.Summary
OpenAI has introduced GPT-Rosalind, a new AI model series optimized for life sciences research, including drug discovery, protein engineering, and genomics. By improving scientific reasoning and integrating with over 50 data tools and databases, the model helps researchers synthesize evidence, plan experiments, and navigate complex, multi-step workflows. Named after Rosalind Franklin, the model demonstrates high performance on benchmarks like BixBench and LABBench2 and is currently available via a trusted-access program for qualified enterprise organizations with rigorous safety and security oversight.
(Source：OpenAI)